Literature DB >> 32755116

Pathological features of COVID-19 infection from biopsy and autopsy series.

Sidar Çopur1, Asiye Kanbay2, Barış Afşar3, Rengin Elsürer Afşar3, Mehmet Kanbay1.   

Abstract

Novel coronavirus disease 2019 (COVID-19) which is caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) was first identified in December 2019 in Chinese town Wuhan and considered as a pandemic by World Health Organization. The disease has variety of symptoms including fever, shortness of breath, cough, fatigue, loss of smell and taste and diarrhea. While the majority of cases have mild symptoms, some progress to viral pneumonia, multi-organ failure, or cytokine storm and mortality is mostly caused by hypoxemic respiratory failure. Until now, more than 3.5 million people worldwide were infected and more than 240.000 mortality has been occurred. Thus, there is now evidence the disease may affect variety of organs according to accumulating biopsy and autopsy studies. Such pathological studies have potential role on the understanding of clinical outcomes and in the development of novel targeted therapeutic approaches. Given these aforementioned data, in the current manuscript we have summarized the pathological features of COVID-19 derived from biopsy and autopsy series.

Entities:  

Mesh:

Year:  2020        PMID: 32755116     DOI: 10.5578/tt.69611

Source DB:  PubMed          Journal:  Tuberk Toraks        ISSN: 0494-1373


  5 in total

1.  Acute kidney injury in hospitalized COVID-19 patients.

Authors:  Mehmet Kanbay; Alpay Medetalibeyoglu; Asiye Kanbay; Enes Cevik; Cem Tanriover; Arzu Baygul; Naci Şenkal; Hilal Konyaoglu; Timur S Akpinar; Murat Kose; Adrian Covic; Tufan Tukek
Journal:  Int Urol Nephrol       Date:  2021-08-19       Impact factor: 2.266

Review 2.  Role of adrenergic receptor signalling in neuroimmune communication.

Authors:  Sushanta Chhatar; Girdhari Lal
Journal:  Curr Res Immunol       Date:  2021-11-25

3.  Long-term effect of COVID-19 infection on hemodialysis patients: Should we follow hemodialysis patients more closely?

Authors:  Atalay Demiray; Asiye Kanbay; Mehmet Kanbay
Journal:  Clin Kidney J       Date:  2021-12-09

4.  Should we continue to use renin-angiotensin-aldosterone system blockers in patients with COVID-19?

Authors:  Sidar Copur; Asiye Kanbay; Mehmet Kanbay
Journal:  Clin Kidney J       Date:  2022-01-06

Review 5.  Post-acute COVID-19 syndrome and kidney diseases: what do we know?

Authors:  Sidar Copur; Metehan Berkkan; Carlo Basile; Katherine Tuttle; Mehmet Kanbay
Journal:  J Nephrol       Date:  2022-03-16       Impact factor: 4.393

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.